Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial.

By H. Thiele, U. Zeymer, F. Neumann, Miroslaw Ferenc, H. Olbrich, J. Hausleiter, Antoinette de Waha, G. Richardt, M. Hennersdorf, K. Empen and 10 more. The Lancet, 2013

777 citations recorded by the source corpus.

Subfields: Biomedical Engineering, Cardiology and Cardiovascular Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/2a83d94ea7183a40661ee198a3945c51a9f23122

Citations in the corpus

• 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure (2016, neutral): “Recently the IABP-SHOCK II trial showed that the use of an IABP did not improve outcomes in patients suffering from AMI and cardiogenic shock.(585,586)”